Evidence map›Paper›PMID 25812148›Full record

ArticleMolecules (Basel, Switzerland)2015

Synthesis and biological properties of 5-(1H-1,2,3-triazol-4-yl)isoxazolidines: a new class of C-nucleosides.

Salvatore V Giofrè, Roberto Romeo, Caterina Carnovale, Raffaella Mancuso, Santa Cirmi, Michele Navarra, Adriana Garozzo, Maria A Chiacchio

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Approaches to the synthesis of heterocyclicRussian chemical bulletin = Izvestiia Akademii nauk. Seriia khimicheskaia · 2023
    Review
  5. Article
  6. Role of main RNA modifications in cancer: NSignal transduction and targeted therapy · 2022
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Synthesis of spiro[isoindole-1,5'-isoxazolidin]-3(2Beilstein journal of organic chemistry · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Salvatore V GiofrèDipartimento Scienze del Farmaco e Prodotti per la Salute, Università di Messina, Via S.S. Annunziata, Messina 98168, Italy. sgiofre@unime.it.
Roberto RomeoDipartimento Scienze del Farmaco e Prodotti per la Salute, Università di Messina, Via S.S. Annunziata, Messina 98168, Italy. robromeo@unime.it.
Caterina CarnovaleDipartimento Scienze del Farmaco e Prodotti per la Salute, Università di Messina, Via S.S. Annunziata, Messina 98168, Italy. ccarnovale@unime.it.
Raffaella MancusoDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, Via P. Bucci, 12/C, Arcavacata di Rende (CS) 87036, Italy. raffaella.mancuso@unical.it.
Santa CirmiDipartimento Scienze del Farmaco e Prodotti per la Salute, Università di Messina, Via S.S. Annunziata, Messina 98168, Italy. scirmi@unime.it.
Michele NavarraDipartimento Scienze del Farmaco e Prodotti per la Salute, Università di Messina, Via S.S. Annunziata, Messina 98168, Italy. mnavarra@unime.it.
Adriana GarozzoDipartimento di Scienze Bio-mediche, Università di Catania, Via Androne 81, Catania 95124, Italy. agar@unict.it.
Maria A ChiacchioDipartimento Scienze del Farmaco, Università di Catania, Viale A. Doria 6, Catania 95125, Italy. ma.chiacchio@unict.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of C-nucleosides, featuring the presence of a 1,2,3-triazole ring linked to an isoxazolidine system, has been designed as mimetics of the pyrimidine nucleobases. An antiproliferative effect was observed for compounds 17a and 17b: the growth inhibitory effect reaches the 50% in HepG2 and HT-29 cells and increases up to 56% in the SH-SY5Y cell line after 72 h of incubation at a 100 µM concentration.

Indexed as

Antineoplastic AgentsCell ProliferationDrug Screening Assays, AntitumorHep G2 CellsHT29 CellsHumansIsoxazolesMolecular MimicryMolecular StructureNucleosidesPyrimidinesStructure-Activity RelationshipAntineoplastic AgentsIsoxazolesNucleosidespyrimidinePyrimidines

Identifiers

PMID25812148
PMCPMC6272400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.